Gland Pharma Secures USFDA Approval for Generic Breast Cancer Drug
Gland Pharma made a significant announcement on Monday, revealing its latest milestone achievement: receiving approval from the US health regulatory body for the marketing of a generic medication tailored for treating breast cancer. In a statement released, Gland Pharma disclosed that it has secured the green light from the US Food and Drug Administration (USFDA) … Read more